Merck Paves the Way for its Innovation Hub in Southern China
Company signed agreement with Guangzhou Development District
Merck signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant to this agreement, Merck will establish an innovation hub in Guangzhou scheduled to open September 2019.
“China is a major innovation hotspot and one of our most important growth markets. We are now creating a strong platform for Merck and our partners to drive innovation in Southern China. At the same time, we are strengthening our footprint in this vibrant ecosystem of innovation,” said Kai Beckmann, Member of the Executive Board of Merck and CEO Performance Materials, at the signing ceremony in Guangzhou.
“We are very glad that Merck has chosen Guangzhou Development District,” said Hong Qian, Deputy Director of Huangpu District Government of the Guangzhou City. “With the extensive facilities and innovation ecosystem in Guangdong, we believe that the Merck Guangdong Innovation Hub will be successful.”
Designed to take advantage of the innovation ecosystem consisting of numerous technology companies, startups, universities, research institutes, and related facilities in Guangdong, the Merck Guangdong Innovation Hub will be located at the International Biotech Island of Guangzhou Development District, Huangpu District, Guangzhou City. The 700 sqm hub will be equipped with a showroom to demonstrate Merck’s latest technologies, innovation projects and future research direction of the three business sectors of Merck, Healthcare, Life Science and Performance Materials.
This innovation hub will integrate the advanced technologies and expertise of Merck and its partners such as startups, academic institutions, business partners, and local government. Together they will develop innovative technologies and promote business growth in the strategic markets of the Guangdong-Hong Kong-Macao Greater Bay Area, while fostering innovative thinking among Merck employees. The innovation hub will seize new opportunities in Healthcare, Life Science and Performance Materials and cross-sectors, with the goal of bringing new technologies and solutions to the Chinese market and to the world.
Merck has continuously invested in the development of innovation of China. Merck Accelerator for example has programs in Darmstadt and started a recent one in China . Selected startups will have the chance to join the innovation hub in China first and then move to the Innovation Center at Merck headquarters in Darmstadt, Germany, to develop their projects further and explore the European market. Merck aims to identify and support promising startups with a focus on those operating in the fields of healthcare, life science, performance materials, biotech and other emerging technology fields in their seed to series A funding phase. The three-month China Accelerator Program will start in 2019 and will host five to eight startups each time. The application period is already open and runs until January 25, 2019.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
